Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 8 Pain 7 Cancer Pain 3 Pancreatic Neoplasms 2 Breast Neoplasms 2 Breakthrough Pain 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vipoma 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Thymoma 1 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Standard Opioid Analgesic Treatment of Cancer-related Chronic Pain. 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Sarcoma 1 Salivary Gland Neoplasms 1 Respiratory Insufficiency 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Sirolimus 1 Ketamine 1 Fentanyl 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Epilepsy × Fentanyl × Clear all

NCT07165262 2025-09-10

ECOG-Anaes

Children's Cancer Hospital Egypt 57357

Phase 3 Active not recruiting

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡